Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

Lukas Käsmann, Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Claus Belka, Farkhad Manapov